Abstract
Background
The number of hospitalized young coronavirus disease 2019 (COVID-19) patients has increased significantly. However, specific data about COVID-19 patients under 65 years old who are admitted to the hospital are scarce.
Methods
The COVID-19 patients under 65 years old who were admitted to the hospital in Sichuan Province, Renmin Hospital of Wuhan University, and Wuhan Red Cross Hospital were included in this study. Demographic information, laboratory data and clinical treatment courses were extracted from electronic medical records. Risk factors associated with oxygen therapy were explored.
Results
Eight hundred thirty-three COVID-19 patients under 65 years old were included. Of the included patients, 29.4% had one or more comorbidities. Oxygen therapy was required in 63.1% of these patients, and the mortality was 2.9% among the oxygen therapy patients. Fever (odds ratio [OR] 2.072, 95% confidence interval [CI] 1.312–3.271, p = 0.002), dyspnea (OR 2.522, 95% CI 1.213–5.243, p = 0.013), chest distress (OR 2.278, 95% CI 1.160–4.473, p = 0.017), elevated respiratory rate (OR 1.114, 95% CI 1.010–1.228, p = 0.031), and decreased albumin (OR 0.932, 95% CI 0.880–0.987, p = 0.016) and globulin levels (OR 0.929, 95% 0.881–0.980, p = 0.007) were independent factors related to oxygen therapy.
Conclusions
Oxygen therapy is highly required in COVID-19 patients under 65 years old who are admitted to the hospital, but the success rate is high. Respiratory failure-related symptoms, elevated respiratory rate, low albumin and globulin levels, and fever at admission are independent risk factors related to the requirement of oxygen.
Funder
National Key Research and Development Program of China
Sichuan Science and Technology Project
Sichuan Science and Technology Agency Grant
Publisher
Public Library of Science (PLoS)
Reference37 articles.
1. Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy;A De Vito;European review for medical and pharmacological sciences,2020
2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;C Huang;Lancet (London, England),2020
3. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases;LA Vaira;Head & neck,2020
4. Silent COVID-19: what your skin can reveal;C Guarneri;The Lancet Infectious diseases,2020